-
Institut de Recerca Sant Joan de Déu participes in a project that facilitates access to personalised medicine
Institut de Recerca Sant Joan de Déu and SJD Children’s Hospital is participating in the SEHOP-PENCIL project that aims to facilitate access to precision medicine for all children and adolescents with cancer in Spain, regardless of where they live.
-
Share4Rare and CIBERER join forces for rare diseases research
Share4Rare and the Spanish Network in Rare Disease Research (CIBERER) will collaborate to locate patients to promote clinical research initiatives.
-
Gene therapy proved against Muscular Distrophy with the ALBA Synchrotron
A study by the Institut de Recerca Sant Joan de Déu, ICFO, CIBERER and the ALBA Synchrotron has helped demonstrate that gene therapy can reverse the effects of the mutation that causes the symptoms of congenital muscular dystrophy in patient cells.
-
Emotional abuse and stress are risk factors for suicidal behavior in people with first psychotic episodes
Institut de Recerca Sant Joan de Déu study associates stress and emotional abuse in childhood with a greater risk of suicidal behavior in young people with a first psychotic episode.
-
From the common cold virus to severe respiratory illness in children
Dr Cristian Launes and Dr Carmen Múñoz (IRSJD researchers) with Dr Daniel Penela-Sánchez and Dr Georgina Armero started a project in 2017 to understand the severity of rhinovirus and enterovirus infection in children.
-
New tool to predict severity in Nonketotic Hyperglycinemia, a rare disease
An international team led by Dr Àngels García Cazorla, a researcher at the Institut de Recerca Sant Joan de Déu and a pediatric neurologist at the SJD Barcelona Children’s Hospital, has presented a new approach to nonketotic hyperglycinemia that can predict the severity in affected children. The study was published in the journal Annals of Neurology.
-
The size of the corpus callosum could be a possible biomarker for neurodevelopment in fetuses with congenital heart diseases
Research shows that children with congenital heart defects have a smaller corpus callosum at 32-36 weeks of gestation. BCNatal - Fetal Medicine Research Center, formed by professionals from the Institut de Recerca Sant Joan de Déu (IRSJD) and IDIBAPS, leds this research.
-
Findings on how gen ‘YWHAZ’ can alter neuronal development
Dr. Bru Cormand and Noèlia Fernàndez (IRSJD) led a research study where reveals the molecular mechanisms to explain how the YWHAZ gene -related to psychiatric and neurological disorders such as autism and schizophrenia- can alter the neurodevelopmental process.
-
The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first time
Drs. Susana Rives, Montserrat Torrebadell and Nerea Vega (IRSJD) participate in a study led by Dr. Pablo Menéndez, group leader at the Josep Carreras Leukaemia Research Institut, who has identified a previously noticed population of pre-leukemic cells might be responsible for some relapses in B-cell acute lymphoblastic leukemia (B-ALL).
